Global Fundus Cameras Market Set for Expansion, Forecasted to Achieve Significant Growth by 2030
February 14, 2024 11:26 ET
|
Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Fundus Cameras Market by Product (Hybrid Fundus Cameras, Mydriatic Fundus Cameras, Nonmydriatic Fundus Cameras), End User (Hospitals, Ophthalmic...
Ophthalmic Drops Market to Escalate to USD 1.98 Billion by 2030, Driven by Prescription Eye Drops Demand
February 14, 2024 11:19 ET
|
Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Drops Market by Type (Over-the-counter Eye Drops, Prescription Eye Drops), Category (Anesthetic Drops, Antibiotic Drops, Dilation...
Nacuity Pharmaceuticals Announces Expansion of its Business Advisory Board with Appointment of Rare Disease Advocate Daniel Feller
February 14, 2024 09:00 ET
|
Nacuity Pharmaceuticals, Inc.
FORT WORTH, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other...
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
February 14, 2024 07:30 ET
|
Ocugen
Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase 1/2 clinical trial patient MALVERN, Pa., Feb. 14, 2024 ...
Intraocular Lens Market to Soar to USD 8,835 Million by 2033; Driven by Technological Advancements and Aging Population
February 12, 2024 06:21 ET
|
Market.Us
New York, Feb. 12, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Intraocular Lens Market value is projected to exceed USD 8,835 Million by 2033, with a projected CAGR of 6.3% from 2024 to...
EyeMD EMR Healthcare Systems Inc. Receives the 2024 Best in KLAS Award for Ophthalmology EMR
February 07, 2024 15:09 ET
|
EyeMD EMR Healthcare Systems, Inc.
EyeMD EMR, a leading provider of clinical software solutions designed specifically for eye care, announced its receipt of the Best in KLAS Award.
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
February 07, 2024 08:00 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to...
Global Ophthalmology Market Poised for Robust Growth: Comprehensive Research Forecast 2023-2030 Highlights Disease, Product, and End-User Segments
February 07, 2024 04:30 ET
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses...
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
February 06, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...